Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
$179,737N01FY2016AINIH
Advanced Bioscience Laboratories, Inc., Kensington MD
Investigators
Abstract
This contract provides for manufacturing vaccine and biologic products in accordance with relevant cGMP Phase I/II FDA regulations and guidelines under the NIAID Manufacture and Characterization Services (MCS) for Vaccines and Other Biologics for Infectious Diseases Program.
View original record on NIH RePORTER →